We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.89T
$795M 5.51%
2,995,228
-229,211
-7% -$58.5M
AAPL icon
2
Apple
AAPL
$4.76T
$662M 4.59%
4,360,040
-43,241
-1% -$6.38M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.22T
$359M 2.49%
3,762,130
-385,645
-9% -$37M
MRK icon
4
Merck
MRK
$316B
$340M 2.36%
3,470,062
+264,370
+8% +$28.5M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$68.6B
$264M 1.83%
348,988
-33,980
-9% -$25.6M
TMO icon
6
Thermo Fisher Scientific
TMO
$196B
$240M 1.67%
452,703
+13,509
+3% +$7.61M
UNH icon
7
UnitedHealth
UNH
$394B
$233M 1.62%
536,484
+44,209
+9% +$21.3M
AMGN icon
8
Amgen
AMGN
$198B
$224M 1.55%
1,005,806
+26,020
+3% +$6.39M
DHR icon
9
Danaher
DHR
$127B
$218M 1.51%
1,058,842
-6,399
-0.6% -$1.46M
V icon
10
Visa
V
$672B
$165M 1.15%
795,947
+7,657
+1% +$1.7M
NVDA icon
11
NVIDIA
NVDA
$5.18T
$156M 1.08%
6,098,910
-154,790
-2% -$3.35M
PG icon
12
Procter & Gamble
PG
$348B
$154M 1.07%
1,125,524
-353,401
-24% -$50.5M
LLY icon
13
Eli Lilly
LLY
$1.03T
$153M 1.06%
484,407
-53,462
-10% -$18M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.22T
$133M 0.93%
1,394,303
-181,749
-12% -$17.5M
TSLA icon
15
Tesla
TSLA
$1.41T
$133M 0.92%
698,264
-170,867
-20% -$29.8M
GILD icon
16
Gilead Sciences
GILD
$163B
$128M 0.89%
1,671,968
+37,461
+2% +$3.1M
MA icon
17
Mastercard
MA
$470B
$124M 0.86%
372,189
+11,857
+3% +$4.31M
JNJ icon
18
Johnson & Johnson
JNJ
$612B
$123M 0.85%
863,501
+172,445
+25% +$27.8M
VRTX icon
19
Vertex Pharmaceuticals
VRTX
$120B
$113M 0.79%
390,908
-78,237
-17% -$23.5M
AMZN icon
20
Amazon
AMZN
$2.62T
$112M 0.78%
1,178,108
-223,547
-16% -$21.6M
ADBE icon
21
Adobe
ADBE
$87.3B
$111M 0.77%
313,012
+52,504
+20% +$18.7M
APD icon
22
Air Products & Chemicals
APD
$66.1B
$111M 0.77%
418,742
+88,467
+27% +$25.8M
CSCO icon
23
Cisco
CSCO
$444B
$109M 0.76%
2,272,367
+194,087
+9% +$9.48M
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
$108M 0.75%
577,620
-230,252
-29% -$36.9M
ADI icon
25
Analog Devices
ADI
$188B
$105M 0.73%
578,644
-2,818
-0.5% -$505K

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.